Updated March 2026
Yes — hair thinning is reported by a meaningful percentage of people on GLP-1 medications. Clinical trials for Wegovy (higher-dose semaglutide) listed hair loss in about 3% of participants. The good news: it's almost always temporary.
The main cause is telogen effluvium — a form of temporary hair shedding triggered by physical stress on the body. Rapid weight loss (losing more than 1–2 lbs per week) is a well-known trigger. Your body redirects nutrients away from hair follicles during periods of caloric deficit or metabolic change.
Nutritional deficiencies (especially protein, iron, zinc, and biotin) from eating much less can also contribute.
In most cases, yes. Telogen effluvium is self-limiting — hair typically starts regrowing within 3–6 months once your body adjusts to the new weight or the weight loss slows. Unlike genetic hair loss, it doesn't permanently damage follicles.